Evidence map›Paper›PMID 38398160›Full record

ArticleCancers2024

Interval Cancer in Population-Based Colorectal Screening Programmes: Incidence and Characteristics of Tumours.

Mercedes Vanaclocha-Espí, Marina Pinto-Carbó, Josefa Ibáñez, María José Valverde-Roig, Isabel Portillo, Francisco Pérez-Riquelme, Mariola de la Vega, Susana Castán-Cameo, Dolores Salas, Ana Molina-Barceló

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 97% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Mercedes Vanaclocha-EspíFoundation for the Promotion of Health and Biomedical Research in the Valencian Community (FISABIO)-Public Health, 46020 Valencia, Spain.
Marina Pinto-CarbóFoundation for the Promotion of Health and Biomedical Research in the Valencian Community (FISABIO)-Public Health, 46020 Valencia, Spain.
Josefa IbáñezFoundation for the Promotion of Health and Biomedical Research in the Valencian Community (FISABIO)-Public Health, 46020 Valencia, Spain.
María José Valverde-RoigGeneral Directorate of Public Health, Valencian Community, 46020 Valencia, Spain.
Isabel PortilloThe Basque Health Service, 48011 Bilbao, Spain.ORCID 0000-0002-3871-3423
Francisco Pérez-RiquelmeGeneral Directorate of Public Health, Murcia Region, 30008 Murcia, Spain.
Mariola de la VegaGeneral Directorate of Assistance Programmes, 38071 Santa Cruz de Tenerife, Spain.
Susana Castán-CameoGeneral Directorate of Public Health, Valencian Community, 46020 Valencia, Spain.
Dolores SalasFoundation for the Promotion of Health and Biomedical Research in the Valencian Community (FISABIO)-Public Health, 46020 Valencia, Spain.
Ana Molina-BarcelóFoundation for the Promotion of Health and Biomedical Research in the Valencian Community (FISABIO)-Public Health, 46020 Valencia, Spain.
Generalitat Valenciana · ESFundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana · ESBasque Government · ES

Funding

European Regional Development Fund (ERDF) PI15/02108Instituto de Salud Carlos III PI15/02108
6 · The paper itself

Abstract

The objective of this study is to evaluate interval cancer (IC) in colorectal cancer (CRC) screening, which is CRC diagnosed in an individual after having received a negative faecal occult blood test and before the next invitation to participate in screening. A follow-up study was conducted on a cohort of participants in the first three screening rounds of four colorectal cancer screening programmes in Spain,

Indexed as

colorectal cancerdecision aidsfaecal immunochemical testpersonalisation strategiesscreening

Identifiers

PMID38398160
PMCPMC10887036
OpenAlexW4391815138

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.